0.235

10.13% -0.0265

Accendra Health Inc (ACH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Accendra Health Inc stock is traded at $0.235, with a volume of 2.94M. It is down -10.13% in the last 24 hours and down -78.04% over the past month. Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

Previous Close:

$0.2615

Open:

$0.2705

24h Volume:

2.94M

Relative Volume:

1.48

Market Cap:

$18.07M

Revenue:

$4.72B

Net Income/Loss:

$-123.85M

P/E Ratio:

-0.0164

EPS:

-14.2981

Net Cash Flow:

$-303.12M

1W Performance:

-45.09%

1M Performance:

-78.04%

6M Performance:

-92.94%

1Y Performance:

+0.00%

1-Day Range:

$0.2169

$0.29

1-Week Range:

$0.2169

$0.44

52-Week Range:

$0.2169

$4.6887

Accendra Health Inc Stock (ACH) Company Profile

Name

Accendra Health Inc

Sector

Healthcare (1052)

Industry

Medical Distribution (11)

Phone

(804) 277-4304

Address

4435 WATERFRONT DRIVE, GLEN ALLEN

Employee

6,500

Twitter

Next Earnings Date

2026-10-29

Latest SEC Filings

ACH's Discussions on Twitter

Compare ACH vs MCK, COR, CAH, HSIC, AHG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACH Accendra Health Inc	0.235	18.07M	4.72B	-123.85M	-303.12M	-14.30
MCK Mckesson Corp	1,004.84	117.15B	403.43B	5.10B	5.41B	38.47
COR Cencora Inc	340.92	65.06B	328.68B	2.55B	1.56B	13.03
CAH Cardinal Health Inc	254.06	58.83B	250.74B	1.55B	4.39B	6.5398
HSIC Henry Schein Inc	86.38	9.63B	13.38B	418.00M	391.00M	3.3112
AHG Akso Health Group Adr	1.35	1.16B	14.85M	-136.07M	7.25M	-0.4726

Accendra Health Inc Stock (ACH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-11-26	Downgrade	Citigroup	Buy → Neutral
Aug-11-26	Downgrade	Robert W. Baird	Outperform → Neutral
Nov-03-25	Downgrade	UBS	Buy → Neutral
Jul-19-24	Upgrade	Citigroup	Neutral → Buy
Feb-26-24	Initiated	Leerink Partners	Market Perform
Jan-03-24	Initiated	Barclays	Equal Weight
Oct-13-22	Downgrade	Citigroup	Buy → Neutral
Oct-12-22	Downgrade	BofA Securities	Buy → Underperform
Oct-12-22	Downgrade	Robert W. Baird	Outperform → Neutral
Apr-26-22	Resumed	Citigroup	Buy
Apr-01-22	Resumed	Credit Suisse	Neutral
Mar-30-22	Resumed	JP Morgan	Underweight
Mar-23-22	Upgrade	HSBC Securities	Reduce → Hold
Apr-08-21	Upgrade	JP Morgan	Neutral → Overweight
Mar-08-21	Upgrade	Goldman	Sell → Buy
Dec-17-20	Upgrade	UBS	Neutral → Buy
Sep-25-20	Upgrade	Barclays	Underweight → Equal Weight
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy
Jul-21-20	Upgrade	Robert W. Baird	Neutral → Outperform
Jul-14-20	Upgrade	Credit Suisse	Neutral → Outperform
May-05-20	Downgrade	Robert W. Baird	Outperform → Neutral
Apr-23-20	Resumed	Credit Suisse	Neutral
Jan-21-20	Upgrade	Robert W. Baird	Neutral → Outperform
Jan-07-20	Downgrade	Goldman	Neutral → Sell
Nov-15-19	Upgrade	CLSA	Underperform → Outperform
Sep-06-19	Reiterated	BofA/Merrill	Neutral
Apr-10-19	Reiterated	BofA/Merrill	Neutral
Apr-03-19	Upgrade	BofA/Merrill	Neutral → Buy
Apr-01-19	Upgrade	JP Morgan	Underweight → Overweight
Jan-18-19	Upgrade	HSBC Securities	Hold → Buy
Jan-17-19	Initiated	UBS	Neutral
Jan-15-19	Upgrade	CLSA	Underperform → Outperform
Dec-14-18	Downgrade	Morgan Stanley	Overweight → Underweight
Dec-12-18	Downgrade	Goldman	Buy → Neutral
Sep-28-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-11-18	Downgrade	CLSA	Outperform → Sell
Apr-10-18	Upgrade	Credit Suisse	Neutral → Outperform
Mar-26-18	Upgrade	Goldman	Sell → Neutral
Nov-02-17	Downgrade	HSBC Securities	Buy → Hold
Mar-24-16	Upgrade	Goldman	Sell → Neutral
Dec-07-15	Downgrade	Goldman	Neutral → Sell
Aug-31-15	Upgrade	Credit Suisse	Underperform → Neutral
Aug-01-12	Initiated	HSBC Securities	Underweight
Aug-05-09	Upgrade	Citigroup	Sell → Buy
Dec-01-08	Downgrade	HSBC Securities	Neutral → Underweight

View All

Accendra Health Inc Stock (ACH) Latest News

Oct 13, 2026

In brief: Trace Medical acquisition, HealthTap launch, Accendra Health notice - HME News

Oct 13, 2026

Oct 12, 2026

Accendra Health on notice from NYSE - HME News

Oct 12, 2026

Oct 09, 2026

Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard - Business Wire

Oct 09, 2026

New Strong Sell Stocks for October 9th - Zacks Investment Research

Oct 09, 2026

Oct 06, 2026

Form 4 Accendra Health Inc For: 6 October By Investing.com - Investing.com Nigeria

Oct 06, 2026

A 283,554-share grant to Accendra Health (ACH) CEO vests one-third annually over three years. - Stock Titan

Oct 06, 2026

Form 4 ACCENDRA HEALTH INC/VA/ For: Oct 05 Filed by: Gardner-Smith Kenneth - StreetInsider

Oct 06, 2026

New Strong Sell Stocks for October 6th - Zacks Investment Research

Oct 06, 2026

Sep 28, 2026

Lobbying Update: $200,000 of ACCENDRA HEALTH INC. lobbying was just disclosed - Quiver Quantitative

Sep 28, 2026

Accendra Health Inc Revenue Breakdown – DUS:6OM - tradingview.com

Sep 28, 2026

Sep 26, 2026